Jaguar Gene Therapy
Scope
Date
~
-
Bio & PharmaSeegene's COVID-19 diagnostic product wins Product of the Year Award
Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...
Dec 16, 2022 (Gmt+09:00)
-
Bio & PharmaS. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
-
Bio & PharmaSamsung Biologics in CDO deal talks with global pharma firm
FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...
Nov 07, 2022 (Gmt+09:00)
-
Bio & PharmaK-bio firms embrace gene therapy CDMO as Samsung looks the other way
South Korea’s major biopharmaceutical companies are rapidly embracing the cell and gene therapy business under a contract drug-making mechanis...
Aug 05, 2022 (Gmt+09:00)
-
Bio & PharmaLG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Bio & PharmaKolon Life inks technology transfer deal with Juniper Biologics
South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...
Apr 13, 2022 (Gmt+09:00)
-
Bio & PharmaSK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
-
Bio & PharmaSamsung’s Life Science Fund invests in US biotech Jaguar Gene Therapy
Samsung Group’s 150 billion won ($124 million) Life Science Fund launched last year has chosen a leading US gene therapy development company a...
Mar 30, 2022 (Gmt+09:00)
-
Pre-IPOsSK Pharmteco to raise up to $498 mn on $5 bn valuation
SK Pharmteco, a contract development and manufacturing organization (CDMO) for pharmaceuticals, is slated to raise 400 billion ($332.2 million) to 6...
Jan 10, 2022 (Gmt+09:00)
-
Pharamaceuticals, biotechCelltrion to conduct tests on Omicron variant detected in Korea
Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...
Dec 06, 2021 (Gmt+09:00)
-
COVID-19SK seeks to make Pfizer, Merck COVID-19 pills in CMO deals
SK Inc., the investment and holding company of South Korea’s SK Group, is seeking to make COVID-19 treatment pills developed by Pfizer Inc. an...
Nov 17, 2021 (Gmt+09:00)
language -
Green Cross' two Kosdaq-listed cell therapy arms to merge
South Korea's pharmaceutical group Green Cross Corp., or GC Pharma, will combine its two cell therapy developers listed on the junior Kosdaq market ...
Jul 18, 2021 (Gmt+09:00)
-
HealthcareKT makes another step beyond telecom, enters digital therapy sector
The telecom companies in South Korea, one after another, are taking bold steps outside their traditional turf of mobile business. They are eng...
Jun 15, 2021 (Gmt+09:00)
-
Korean foodSK acquires 70% stake in Yposkesi to jump into cell, gene CMO business
SK Inc., the holding and investment company of SK Group, South Korea’s third-largest conglomerate, has acquired a 70% stake in Yposkesi, a Fre...
Mar 31, 2021 (Gmt+09:00)
-
Mergers & AcquisitionsSK in talks to buy French biologics contract manufacturer
SK Holdings is in the early stages of negotiations to acquire France’s biologic contract manufacturing organization (CMO) Yposkesi, in a move ...
Dec 17, 2020 (Gmt+09:00)
language
